#15,742
Although the initial concerns with the COVID pandemic were handling acute illnesses and minimizing deaths, by mid-2020 it had become apparent that some (perhaps many) COVID survivors were experiencing slow recoveries, and prolonged (and sometimes severe) sequelae.
Some `recovered' patients have been left with lasting lung, heart, or kidney damage while others have experienced lingering neurological manifestations ranging from relatively mild (headaches, dizziness, anosmia, mild confusion, etc.) to more profound (seizures, stupor, loss of consciousness, etc.) to potentially fatal (ischemic stroke, cerebral hemorrhage, muscle injury (rhabdomyolysis), etc.).
Some experts have warned we may see huge increases in COVID-19 related heart failure and neurological diseases in the years ahead.
Coronavirus Disease 2019 (COVID-19) and the Heart—Is Heart Failure the Next Chapter?
Clyde W. Yancy, MD, MSc1,2; Gregg C. Fonarow, MD3,4
JAMA Cardiol. Published online July 27, 2020. doi:10.1001/jamacardio.2020.3575
Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms
Emily A. Troyer, Jordan N. Kohn, and Suzi Hong
Although a causal link to the 1918 H1N1 pandemic virus has not been established, in the decade following the 1918 pandemic the world saw a huge increase in Parkinsonism and other neurological conditions, including Encephalitis Lethargica (see The Lancet: COVID-19: Can We Learn From Encephalitis Lethargica?).
Last October, in UK NIHR: Living With COVID-19 (Long COVID), we looked at the potential for many patients to develop a Post Viral Fatigue syndrome - similar to ME/CFS - that could cause permanent disability.
The CDC addressed these `long-term' post-COVID symptoms last fall in:
Updated Nov. 10, 2020CDC is actively working to learn more about the whole range of short- and long-term health effects associated with COVID-19. As the pandemic unfolds, we are learning that many organs besides the lungs are affected by COVID-19 and there are many ways the infection can affect someone’s health.While most persons with COVID-19 recover and return to normal health, some patients can have symptoms that can last for weeks or even months after recovery from acute illness. Even people who are not hospitalized and who have mild illness can experience persistent or late symptoms.
Multi-year studies are underway to further investigate. CDC continues to work to identify how common these symptoms are, who is most likely to get them, and whether these symptoms eventually resolve.
Next week (Thurs Jan 28th) the CDC will hold a COCA (Clinician Outreach & Communication Activity) Call on clinician's experience with `Long COVID' cases. I expect this to be a heavily attended presentation.
These presentations are often technical, and are of greatest interest to clinicians and healthcare providers, but also may be of interest to the general public.
If you are unable to attend the live presentation, these webinars are always archived and available for later viewing at this LINK.
Treating Long COVID: Clinician Experience with Post-Acute COVID-19 Care
Free Continuing Education
Overview
For some people, the effects of COVID-19 can last well beyond the immediate illness. Patients and clinicians across the United States are reporting long-term effects of COVID-19, commonly referred to as long COVID. Symptoms may include cognitive difficulties, fatigue, and shortness of breath. In some patients, critical illness from COVID-19 may be the cause of persistent symptoms, but many patients with long-term effects had mild or asymptomatic acute COVID-19 infection. During this COCA Call, presenters will share their firsthand experiences with treating long COVID, focusing on the pulmonary, neurologic, and psychological aspects. They will also describe their experiences with establishing clinics that provide care for patients with these long-term effects.
Presenters
Alfonso C Hernandez-Romieu, MD, MPH
LCDR, U.S. Public Health Service
Late Sequelae Unit, Clinical Team
COVID-19 Response
Centers for Disease Control and Prevention
Jennifer Possick, MD
Associate Professor, Section of Pulmonary, Critical Care and Sleep Medicine
Department of Internal Medicine
Yale University School of Medicine
Allison Navis, MD
Assistant Professor, Division Neuro-Infectious Diseases
Icahn School of Medicine at Mount Sinai
Mount Sinai Health System
Call Materials
None at this time
Call Details
When:
Thursday, January 28, 2021,
2:00 PM – 3:00 PM ET
Webinar Link:
https://www.zoomgov.com/j/1606808037?pwd=NUx3a1hQd2tVWVZBU0JobFgxUDJ2Zz09
Passcode: 594536
Dial In:
US: +1 669 254 5252
or +1 646 828 7666
or +1 669 216 1590
or +1 551 285 1373
International number
iPhone one-tap:
US: +16692545252,,1606808037#,,,,,,0#,,594536# or +16468287666,,1606808037#,,,,,,0#,,594536#
Webinar ID: 160 680 8037Add to Calendar
